| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 289 |
| 1 | ADALIMUMAB | 228 |
| 2 | METHOTREXATE SODIUM | 194 |
| 3 | RITUXIMAB | 187 |
| 4 | METHOTREXATE | 181 |
| 5 | AZATHIOPRINE | 137 |
| 6 | ERGOCALCIFEROL | 98 |
| 7 | ROMIPLOSTIM | 91 |
| 8 | INFLIXIMAB | 87 |
| 9 | DANAZOL | 86 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DYCLONINE HYDROCHLORIDE | 29 | 0.3053 |
| 1 | ACONITUM NAPELLUS, BELLADONNA, CHAMOMILLA | 1 | 0.0400 |
| 2 | HUMAN RHO(D) IMMUNE GLOBULIN | 39 | 0.0380 |
| 3 | PAROMOMYCIN SULFATE | 4 | 0.0377 |
| 4 | DANAZOL | 86 | 0.0303 |
| 5 | HYDROCORTISONE VALERATE | 17 | 0.0271 |
| 6 | VACCINIA IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | 2 | 0.0227 |
| 7 | ADENINE | 1 | 0.0204 |
| 8 | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | 1 | 0.0115 |
| 9 | BENZNIDAZOLE | 1 | 0.0098 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 434 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 223 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 211 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 201 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 184 |
| 5 | Vitamin C [EPC] | 164 |
| 6 | Purine Antimetabolite [EPC] | 137 |
| 7 | Kinase Inhibitor [EPC] | 118 |
| 8 | Mood Stabilizer [EPC] | 104 |
| 9 | Provitamin D2 Compound [EPC] | 98 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thrombopoietin Receptor Agonist [EPC] | 91 | 0.0060 |
| 1 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 2 | Rifamycin Antimycobacterial [EPC] | 16 | 0.0046 |
| 3 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 6 | 0.0034 |
| 4 | Provitamin D2 Compound [EPC] | 98 | 0.0033 |
| 5 | Androgen [EPC] | 90 | 0.0033 |
| 6 | Human Immunoglobulin G [EPC] | 67 | 0.0032 |
| 7 | Interleukin-17 Receptor A Antagonist [EPC] | 6 | 0.0029 |
| 8 | Interferon gamma [EPC] | 4 | 0.0028 |
| 9 | Interleukin-36 Receptor Antagonist [EPC] | 1 | 0.0025 |